Cargando…
Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands
BACKGROUND: The parasite Toxoplasma gondii (T. gondii) is recognized as one of the major foodborne pathogens with a high human disease burden. To control T. gondii infections in pigs, European Food Safety Agency (EFSA) advises serological testing of pigs and audits of pig farms to identify risk fact...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311922/ https://www.ncbi.nlm.nih.gov/pubmed/34311779 http://dx.doi.org/10.1186/s40813-021-00223-0 |
_version_ | 1783729053777264640 |
---|---|
author | Eppink, Dorien M. Wisselink, Henk J. Krijger, Inge M. van der Giessen, Joke W.B. Swanenburg, Manon van Wagenberg, Coen P.A. van Asseldonk, Marcel A.P.M. Bouwknegt, Martijn |
author_facet | Eppink, Dorien M. Wisselink, Henk J. Krijger, Inge M. van der Giessen, Joke W.B. Swanenburg, Manon van Wagenberg, Coen P.A. van Asseldonk, Marcel A.P.M. Bouwknegt, Martijn |
author_sort | Eppink, Dorien M. |
collection | PubMed |
description | BACKGROUND: The parasite Toxoplasma gondii (T. gondii) is recognized as one of the major foodborne pathogens with a high human disease burden. To control T. gondii infections in pigs, European Food Safety Agency (EFSA) advises serological testing of pigs and audits of pig farms to identify risk factors for T. gondii infection. In line with this approach, the aim of the current study was to assess the effectiveness and costs of intervention measures implemented to reduce the T. gondii seroprevalence on finishing pig farms in the Netherlands. A crossover clinical trial was conducted at five case farms were their own control and the cross-over moment was the implementation of interventions to reduce risk factors. Each of the case farms had a farm-specific intervention strategy with one principal intervention measure (neutering of cats, professional rodent control or covering food storage). RESULTS: All finishing pig farms (n = 5) showed a reduction in T. gondii seroprevalence within one year of implementing the intervention strategy. Cat neutering (n = 3) and feed coverage (n = 1) showed statistically significant reductions in seroprevalence. Rodent control (n = 1) did not show a statistically significant reduction. The estimated reduction in seroprevalence in response to the neutering of cats and feed coverage were 67 and 96 %, respectively. CONCLUSIONS: Our work demonstrates that it is possible to reduce the within-farm T. gondii seroprevalence within one year after interventions were implemented to reduce T. gondii risk factors. This information is essential and encouraging for policy makers, food business operators, and farmers to implement in their risk assessment and to apply to food safety control systems. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40813-021-00223-0. |
format | Online Article Text |
id | pubmed-8311922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83119222021-07-28 Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands Eppink, Dorien M. Wisselink, Henk J. Krijger, Inge M. van der Giessen, Joke W.B. Swanenburg, Manon van Wagenberg, Coen P.A. van Asseldonk, Marcel A.P.M. Bouwknegt, Martijn Porcine Health Manag Research BACKGROUND: The parasite Toxoplasma gondii (T. gondii) is recognized as one of the major foodborne pathogens with a high human disease burden. To control T. gondii infections in pigs, European Food Safety Agency (EFSA) advises serological testing of pigs and audits of pig farms to identify risk factors for T. gondii infection. In line with this approach, the aim of the current study was to assess the effectiveness and costs of intervention measures implemented to reduce the T. gondii seroprevalence on finishing pig farms in the Netherlands. A crossover clinical trial was conducted at five case farms were their own control and the cross-over moment was the implementation of interventions to reduce risk factors. Each of the case farms had a farm-specific intervention strategy with one principal intervention measure (neutering of cats, professional rodent control or covering food storage). RESULTS: All finishing pig farms (n = 5) showed a reduction in T. gondii seroprevalence within one year of implementing the intervention strategy. Cat neutering (n = 3) and feed coverage (n = 1) showed statistically significant reductions in seroprevalence. Rodent control (n = 1) did not show a statistically significant reduction. The estimated reduction in seroprevalence in response to the neutering of cats and feed coverage were 67 and 96 %, respectively. CONCLUSIONS: Our work demonstrates that it is possible to reduce the within-farm T. gondii seroprevalence within one year after interventions were implemented to reduce T. gondii risk factors. This information is essential and encouraging for policy makers, food business operators, and farmers to implement in their risk assessment and to apply to food safety control systems. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40813-021-00223-0. BioMed Central 2021-07-26 /pmc/articles/PMC8311922/ /pubmed/34311779 http://dx.doi.org/10.1186/s40813-021-00223-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Eppink, Dorien M. Wisselink, Henk J. Krijger, Inge M. van der Giessen, Joke W.B. Swanenburg, Manon van Wagenberg, Coen P.A. van Asseldonk, Marcel A.P.M. Bouwknegt, Martijn Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands |
title | Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands |
title_full | Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands |
title_fullStr | Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands |
title_full_unstemmed | Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands |
title_short | Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands |
title_sort | effectiveness and costs of interventions to reduce the within-farm toxoplasma gondii seroprevalence on pig farms in the netherlands |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311922/ https://www.ncbi.nlm.nih.gov/pubmed/34311779 http://dx.doi.org/10.1186/s40813-021-00223-0 |
work_keys_str_mv | AT eppinkdorienm effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands AT wisselinkhenkj effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands AT krijgeringem effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands AT vandergiessenjokewb effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands AT swanenburgmanon effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands AT vanwagenbergcoenpa effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands AT vanasseldonkmarcelapm effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands AT bouwknegtmartijn effectivenessandcostsofinterventionstoreducethewithinfarmtoxoplasmagondiiseroprevalenceonpigfarmsinthenetherlands |